Target Name: NPM2
NCBI ID: G10361
Review Report on NPM2 Target / Biomarker Content of Review Report on NPM2 Target / Biomarker
NPM2
Other Name(s): Nucleoplasmin-2 | Nucleophosmin/nucleoplasmin 2, transcript variant 1 | NPM2 variant 1 | Nucleoplasmin-2 (isoform 1) | nucleophosmin/nucleoplasmin 2 | OTTHUMP00000161773 | NPM2_HUMAN | Nucleoplasmin 2 | MGC78655

NPM2: A Protein at the Intersection of Cellular Regulation and Drug Development

NPM2, or nucleoplasmin-2, is a protein that is expressed in various tissues throughout the body. It is a key player in the regulation of cell growth, apoptosis, and DNA replication, and is implicated in a wide range of biological processes. As a result, NPM2 has emerged as a promising drug target and biomarker for a variety of diseases.

The NPM2 protein is composed of several subunits that are responsible for different functions in the cell. One of the most well-studied subunit is the NPM2A subunit, which is a 22kDa protein that is expressed in most tissues. The NPM2A subunit is involved in the regulation of DNA replication, and has been shown to play a role in the development of various diseases, including cancer.

Another subunit of NPM2 is the NPM2B subunit, which is a 14kDa protein that is expressed in the brain and other tissues. The NPM2B subunit is involved in the regulation of cell apoptosis, and has been implicated in a variety of neurological and psychiatric diseases.

In addition to the NPM2A and NPM2B subunits, there are several other subunits of NPM2 that have been identified and studied, including the NPM2C subunit, the NPM2D subunit, and the NPM2E subunit. These subunits are involved in various functions in the cell, including cell signaling, DNA replication, and apoptosis.

Despite the wide range of functions associated with NPM2, the precise mechanisms by which it regulates these processes are not well understood. However, several studies have identified important roles for NPM2 in various cellular processes, including the regulation of cell cycle progression, the control of DNA replication, and the regulation of cell apoptosis.

One of the key features of NPM2 is its ability to interact with a variety of different proteins, including other nucleoplasmin proteins, as well as proteins involved in cell signaling and apoptosis. These interactions are thought to play a important role in the regulation of NPM2-mediated processes, and may be targets for future drug development.

In addition to its role in cellular regulation, NPM2 is also of interest as a potential drug target. Several studies have shown that inhibiting NPM2 can have a variety of different effects on cellular processes, including the regulation of cell cycle progression, the control of DNA replication, and the regulation of cell apoptosis. These effects make NPM2 an attractive target for small molecule inhibitors, as well as antibodies that can selectively target NPM2.

In conclusion, NPM2 is a protein that is involved in a wide range of cellular processes, including cell growth, apoptosis, and DNA replication. Its role in these processes makes NPM2 an attractive target for drug development, and the study of its mechanisms of action is an important area of research. As the study of NPM2 continues, it is likely that new insights will emerge into its role in various biological processes, and its potential as a drug target.

Protein Name: Nucleophosmin/nucleoplasmin 2

Functions: Core histones chaperone involved in chromatin reprogramming, specially during fertilization and early embryonic development. Probably involved in sperm DNA decondensation during fertilization

The "NPM2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPM2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NPM3 | NPNT | NPPA | NPPA-AS1 | NPPB | NPPC | NPR1 | NPR2 | NPR3 | NPRL2 | NPRL3 | NPS | NPSR1 | NPSR1-AS1 | NPTN | NPTN-IT1 | NPTX1 | NPTX2 | NPTXR | NPVF | NPW | NPY | NPY1R | NPY2R | NPY4R | NPY4R2 | NPY5R | NPY6R | NQO1 | NQO2 | NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK | NRL | NRM | NRN1 | NRN1L | NRON | NRP1 | NRP2 | NRROS | NRSN1 | NRSN2 | NRSN2-AS1 | NRTN | NRXN1 | NRXN2 | NRXN2-AS1 | NRXN3 | NSA2